BKMHD - 102 7671 EKTACHROME R-3 FIRST DEVELOPER REP

  • MSDS: BKMHD
  • Manufacturer: EASTMAN KODAK CO
  • Product Name: 102 7671 EKTACHROME R-3 FIRST DEVELOPER REP
  • National Stock Number: 6750-01-201-9678
Product Identification

Product ID:102 7671 EKTACHROME R-3 FIRST DEVELOPER REP
MSDS Date:02/13/1991
FSC:6750
NIIN:01-201-9678
MSDS Number: BKMHD

Responsible Party
EASTMAN KODAK CO.
343 STATE STREET
ROCHESTER, NY 14650
US

Emergency Phone: 716-722-5151 (72-1)

Info Phone: 716-722-5151

Cage: 19139

Contractor
EASTMAN KODAK CO GOVERNMENT MARKETS CONTRACTS
ROCHESTER, NY 14650-1115 US

Telephone: 716-722-5151/(800) 242-2424

Cage: 19139

Ingredients

WATER

CAS: 7732-18-5

RTECS: ZC0110000

Fraction By Weight: 60 - 70%


POTASSIUM SULFITE

CAS: 10117-38-1

Fraction By Weight: 10 - 15%


POTASSIUM CARBONATE

CAS: 584-08-7

RTECS: TS7750000

Fraction By Weight: 10 - 15%


POTASSIUM HYDROQUINONE MONOSULFONATE (PRINCIPAL HAZARDOUS

CAS: 21799-87-1

Fraction By Weight: 5 - 10%


SODIUM CARBONATE

CAS: 497-19-8

RTECS: VZ4050000

Fraction By Weight: 1 - 5%

Hazards

Routes of Entry: Inhalation:YES Skin:YES Ingestion:NO
Reports of Carcinogenicity:NTP:NO IARC:NO OSHA:NO
Health Hazards Acute and Chronic:ACUTE-INHALATION:LOW HAZARD FOR
RECOMMENDED HANDLING.EYES:MAY CAUSE TRANSIENT
IRRITATION.SKIN:PROLONGED OR REPEATED SKIN CONTACT MAY CAUSE AN
ALLERGIC SKIN REACTION.INGESTION:EXPECTED TO BE A LOW INGE STION
HAZARD.CHRONIC-NOT GIVEN.
Explanation of Carcinogenicity:THIS PRODUCT CONTAINS NO INGREDIENT
LISTED AS CARCINOGEN BY IARC,NTP, OR OSHA.
Effects of Overexposure:SEE HEALTH HAZARDS SECTION.
Medical Cond Aggravated by Exposure:NONE SPECIFIED BY MANUFACTURER.

First Aid

First Aid:GET MEDICAL ATTENTION IF SYMPTOMS OCCUR.EYES:IMMEDIATELY
FLUSH WITH WATER FOR AT LEAST 15 MINUTES.SKIN:FLUSH WITH PLENTY OF
SOAP & WATER.INHALATION:REMOVE TO FRESH AIR.INGESTION:IF
CONSCIOUS,DRINK 1-2 GLASSES OF WATER. SEEK MEDICAL ATTENTION.

Fire Fighting

Flash Point:NONE
Extinguishing Media:MEDIA APPROPRIATE FOR SURROUNDING FIRE.
Fire Fighting Procedures:USE SELF-CONTAINED BREATHING APPARATUS AND
PROTECTIVE CLOTHING TO PREVENT CONTACT WITH SKIN AND EYES.
Unusual Fire/Explosion Hazard:FIRE/EXCESSIVE HEAT MAY CAUSE PRODUCTION
OF HAZARDOUS DECOMPOSITION PRODUCTS.

Accidental Release

Spill Release Procedures:FLUSH SPILLS TO SEWER WITH LARGE AMOUNT OF
WATER.
Neutralizing Agent:NOT GIVEN

Handling

Handling and Storage Precautions:STORAGE-KEEP CONTAINER TIGHTLY CLOSED
& AWAY FROM OXIDIZERS AND ACIDS.
Other Precautions:AVOID BREATHING VAPORS. AVOID CONTACT WITH
EYES,SKIN,OR CLOTHING. WASH THOROUGHLY AFTER HANDLING.USE
VENTILATION THAT IS ADEQUATE TO KEEP EMPLOYEE EXPOSURE TO AIRBORNE
CONCENTRATIONS BELOW RECOMMENDED EXPOSURE LIMITS.

Exposure Controls

Respiratory Protection:RESPIRATORS ARE NOT NEEDED FOR NORMAL USE.A
NIOSH/MSHA APPROVED AIR PURIFYING RESPIRATOR WITH AN ORGANIC VAPOR
CARTRIDGE OR A POSITIVE PRESSURE AIR SUPPLIED RESPIRATOR WHERE
AIRBORNE CONCENTRATIONS > TLV.
Ventilation:GOOD GENERAL VENTILATION SHOULD BE SUFFICIENT.
Protective Gloves:LATEX OR NEOPRENE
Eye Protection:SAFETY GLASSES W/SIDE SHIELDS OR GOGGLES
Other Protective Equipment:EYE WASH STATION & SAFETY SHOWER.IMPERVIOUS
CLOTHING SUCH AS BOOTS,APRON,WHOLE BODY SUIT MADE FROM NEOPRENE.
Work Hygienic Practices:WASH THOROUGHLY AFTER HANDLING.
Supplemental Safety and Health

Chemical Properties

HCC:B3
Boiling Pt:B.P. Text:>212F,>100C
Vapor Pres:18
Vapor Density:0.6
Spec Gravity:1.28
pH:9.8
Solubility in Water:COMPLETE
Appearance and Odor:CLEAR, LIGHT YELLOW SOLUTION; ODORLESS
Percent Volatiles by Volume:65

Stability

Stability Indicator/Materials to Avoid:YES
STRONG OXIDIZING AGENTS; STRONG ACIDS
Stability Condition to Avoid:EXCESSIVE HEAT AND FLAME
Hazardous Decomposition Products:COMBUSTION MAY PRODUCE OXIDES OF
SULFUR.

Disposal

Waste Disposal Methods:DISCHARGE, TREATMENT, OR DISPOSAL MAY BE SUBJECT
TO FEDERAL, STATE, OR LOCAL LAWS.THIS CHEMICAL FORMULATION IS
EXPECTED TO HAVE A LOW BIOLOGICAL OXYGEN DEMAND,AND IT IS EXPECTED
TO CAUSE LITTLE OXYGEN DEPLETION IF DISCHARGED WITHOUT TREATMENT.

Disclaimer (provided with this information by the compiling agencies):
This information is formulated for use by elements of the Department
of Defense. The United States of America in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. Any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.